Financhill
Buy
68

BTSG Quote, Financials, Valuation and Earnings

Last price:
$35.09
Seasonality move :
-3.62%
Day range:
$34.75 - $35.94
52-week range:
$15.26 - $36.77
Dividend yield:
0%
P/E ratio:
59.74x
P/S ratio:
0.62x
P/B ratio:
3.55x
Volume:
2M
Avg. volume:
2.3M
1-year change:
93.35%
Market cap:
$6.5B
Revenue:
$11.3B
EPS (TTM):
$0.60

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
BTSG
BrightSpring Health Services, Inc.
$3.2B $0.26 10.83% 365.95% $40.31
DRIO
DarioHealth Corp.
$5.7M -$2.42 -32.08% -68.96% $18.25
NRC
National Research Corp.
-- -- -- -- --
POAI
Predictive Oncology, Inc.
$1.5M -- -25.85% -- --
PRVA
Privia Health Group, Inc.
$495.9M $0.22 11.52% 458.59% $31.11
SPOK
Spok Holdings, Inc.
$35.9M $0.24 2.09% 18.18% $20.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
BTSG
BrightSpring Health Services, Inc.
$35.79 $40.31 $6.5B 59.74x $0.00 0% 0.62x
DRIO
DarioHealth Corp.
$11.84 $18.25 $28.4M -- $0.00 0% 6.57x
NRC
National Research Corp.
$15.87 -- $359.6M 22.52x $0.12 3.03% 2.60x
POAI
Predictive Oncology, Inc.
$4.26 -- $3.2M -- $0.00 0% 13.06x
PRVA
Privia Health Group, Inc.
$23.84 $31.11 $2.9B 167.89x $0.00 0% 1.49x
SPOK
Spok Holdings, Inc.
$13.02 $20.00 $268.2M 16.27x $0.31 9.6% 1.93x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
BTSG
BrightSpring Health Services, Inc.
59.75% 3.568 50.52% 0.74x
DRIO
DarioHealth Corp.
29.69% 1.040 75.99% 3.72x
NRC
National Research Corp.
84.83% 2.343 28.57% 0.39x
POAI
Predictive Oncology, Inc.
-2.51% 0.082 17.45% 0.00x
PRVA
Privia Health Group, Inc.
0.87% 0.814 0.2% 1.61x
SPOK
Spok Holdings, Inc.
4.71% 0.927 2.07% 0.97x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
BTSG
BrightSpring Health Services, Inc.
$392M $105.5M 1.57% 4.14% 3.17% $92.2M
DRIO
DarioHealth Corp.
$3M -$9.5M -28.66% -41.55% -189.42% -$7.4M
NRC
National Research Corp.
$20M $7.7M 17.01% 61.55% 22.36% $10.2M
POAI
Predictive Oncology, Inc.
-$179.3K -$3.3M -282.32% -1065.31% -91108.33% -$1.7M
PRVA
Privia Health Group, Inc.
$61M $14.4M 3.42% 3.45% 2.48% $50.8M
SPOK
Spok Holdings, Inc.
$20M $4.5M 10.33% 10.88% 13.38% $7.6M

BrightSpring Health Services, Inc. vs. Competitors

  • Which has Higher Returns BTSG or DRIO?

    DarioHealth Corp. has a net margin of 1.12% compared to BrightSpring Health Services, Inc.'s net margin of -41.48%. BrightSpring Health Services, Inc.'s return on equity of 4.14% beat DarioHealth Corp.'s return on equity of -41.55%.

    Company Gross Margin Earnings Per Share Invested Capital
    BTSG
    BrightSpring Health Services, Inc.
    11.76% $0.26 $4.5B
    DRIO
    DarioHealth Corp.
    60.22% -$3.05 $106.6M
  • What do Analysts Say About BTSG or DRIO?

    BrightSpring Health Services, Inc. has a consensus price target of $40.31, signalling upside risk potential of 12.62%. On the other hand DarioHealth Corp. has an analysts' consensus of $18.25 which suggests that it could grow by 54.14%. Given that DarioHealth Corp. has higher upside potential than BrightSpring Health Services, Inc., analysts believe DarioHealth Corp. is more attractive than BrightSpring Health Services, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    BTSG
    BrightSpring Health Services, Inc.
    11 1 0
    DRIO
    DarioHealth Corp.
    3 1 0
  • Is BTSG or DRIO More Risky?

    BrightSpring Health Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.077, suggesting its more volatile than the S&P 500 by 7.716%.

  • Which is a Better Dividend Stock BTSG or DRIO?

    BrightSpring Health Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BrightSpring Health Services, Inc. pays -- of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BTSG or DRIO?

    BrightSpring Health Services, Inc. quarterly revenues are $3.3B, which are larger than DarioHealth Corp. quarterly revenues of $5M. BrightSpring Health Services, Inc.'s net income of $37.5M is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, BrightSpring Health Services, Inc.'s price-to-earnings ratio is 59.74x while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BrightSpring Health Services, Inc. is 0.62x versus 6.57x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BTSG
    BrightSpring Health Services, Inc.
    0.62x 59.74x $3.3B $37.5M
    DRIO
    DarioHealth Corp.
    6.57x -- $5M -$2.1M
  • Which has Higher Returns BTSG or NRC?

    National Research Corp. has a net margin of 1.12% compared to BrightSpring Health Services, Inc.'s net margin of 11.54%. BrightSpring Health Services, Inc.'s return on equity of 4.14% beat National Research Corp.'s return on equity of 61.55%.

    Company Gross Margin Earnings Per Share Invested Capital
    BTSG
    BrightSpring Health Services, Inc.
    11.76% $0.26 $4.5B
    NRC
    National Research Corp.
    57.82% $0.18 $94.4M
  • What do Analysts Say About BTSG or NRC?

    BrightSpring Health Services, Inc. has a consensus price target of $40.31, signalling upside risk potential of 12.62%. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that BrightSpring Health Services, Inc. has higher upside potential than National Research Corp., analysts believe BrightSpring Health Services, Inc. is more attractive than National Research Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    BTSG
    BrightSpring Health Services, Inc.
    11 1 0
    NRC
    National Research Corp.
    0 0 0
  • Is BTSG or NRC More Risky?

    BrightSpring Health Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National Research Corp. has a beta of 0.447, suggesting its less volatile than the S&P 500 by 55.256%.

  • Which is a Better Dividend Stock BTSG or NRC?

    BrightSpring Health Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research Corp. offers a yield of 3.03% to investors and pays a quarterly dividend of $0.12 per share. BrightSpring Health Services, Inc. pays -- of its earnings as a dividend. National Research Corp. pays out 45.99% of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios BTSG or NRC?

    BrightSpring Health Services, Inc. quarterly revenues are $3.3B, which are larger than National Research Corp. quarterly revenues of $34.6M. BrightSpring Health Services, Inc.'s net income of $37.5M is higher than National Research Corp.'s net income of $4M. Notably, BrightSpring Health Services, Inc.'s price-to-earnings ratio is 59.74x while National Research Corp.'s PE ratio is 22.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BrightSpring Health Services, Inc. is 0.62x versus 2.60x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BTSG
    BrightSpring Health Services, Inc.
    0.62x 59.74x $3.3B $37.5M
    NRC
    National Research Corp.
    2.60x 22.52x $34.6M $4M
  • Which has Higher Returns BTSG or POAI?

    Predictive Oncology, Inc. has a net margin of 1.12% compared to BrightSpring Health Services, Inc.'s net margin of -2156852.78%. BrightSpring Health Services, Inc.'s return on equity of 4.14% beat Predictive Oncology, Inc.'s return on equity of -1065.31%.

    Company Gross Margin Earnings Per Share Invested Capital
    BTSG
    BrightSpring Health Services, Inc.
    11.76% $0.26 $4.5B
    POAI
    Predictive Oncology, Inc.
    -4980.56% -$107.25 -$75.5M
  • What do Analysts Say About BTSG or POAI?

    BrightSpring Health Services, Inc. has a consensus price target of $40.31, signalling upside risk potential of 12.62%. On the other hand Predictive Oncology, Inc. has an analysts' consensus of -- which suggests that it could grow by 956.34%. Given that Predictive Oncology, Inc. has higher upside potential than BrightSpring Health Services, Inc., analysts believe Predictive Oncology, Inc. is more attractive than BrightSpring Health Services, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    BTSG
    BrightSpring Health Services, Inc.
    11 1 0
    POAI
    Predictive Oncology, Inc.
    0 0 0
  • Is BTSG or POAI More Risky?

    BrightSpring Health Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Predictive Oncology, Inc. has a beta of 1.354, suggesting its more volatile than the S&P 500 by 35.357%.

  • Which is a Better Dividend Stock BTSG or POAI?

    BrightSpring Health Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Predictive Oncology, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BrightSpring Health Services, Inc. pays -- of its earnings as a dividend. Predictive Oncology, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BTSG or POAI?

    BrightSpring Health Services, Inc. quarterly revenues are $3.3B, which are larger than Predictive Oncology, Inc. quarterly revenues of $3.6K. BrightSpring Health Services, Inc.'s net income of $37.5M is higher than Predictive Oncology, Inc.'s net income of -$77.6M. Notably, BrightSpring Health Services, Inc.'s price-to-earnings ratio is 59.74x while Predictive Oncology, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BrightSpring Health Services, Inc. is 0.62x versus 13.06x for Predictive Oncology, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BTSG
    BrightSpring Health Services, Inc.
    0.62x 59.74x $3.3B $37.5M
    POAI
    Predictive Oncology, Inc.
    13.06x -- $3.6K -$77.6M
  • Which has Higher Returns BTSG or PRVA?

    Privia Health Group, Inc. has a net margin of 1.12% compared to BrightSpring Health Services, Inc.'s net margin of 1.69%. BrightSpring Health Services, Inc.'s return on equity of 4.14% beat Privia Health Group, Inc.'s return on equity of 3.45%.

    Company Gross Margin Earnings Per Share Invested Capital
    BTSG
    BrightSpring Health Services, Inc.
    11.76% $0.26 $4.5B
    PRVA
    Privia Health Group, Inc.
    10.51% $0.05 $769M
  • What do Analysts Say About BTSG or PRVA?

    BrightSpring Health Services, Inc. has a consensus price target of $40.31, signalling upside risk potential of 12.62%. On the other hand Privia Health Group, Inc. has an analysts' consensus of $31.11 which suggests that it could grow by 30.48%. Given that Privia Health Group, Inc. has higher upside potential than BrightSpring Health Services, Inc., analysts believe Privia Health Group, Inc. is more attractive than BrightSpring Health Services, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    BTSG
    BrightSpring Health Services, Inc.
    11 1 0
    PRVA
    Privia Health Group, Inc.
    14 2 0
  • Is BTSG or PRVA More Risky?

    BrightSpring Health Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Privia Health Group, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock BTSG or PRVA?

    BrightSpring Health Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Privia Health Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BrightSpring Health Services, Inc. pays -- of its earnings as a dividend. Privia Health Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BTSG or PRVA?

    BrightSpring Health Services, Inc. quarterly revenues are $3.3B, which are larger than Privia Health Group, Inc. quarterly revenues of $580.4M. BrightSpring Health Services, Inc.'s net income of $37.5M is higher than Privia Health Group, Inc.'s net income of $9.8M. Notably, BrightSpring Health Services, Inc.'s price-to-earnings ratio is 59.74x while Privia Health Group, Inc.'s PE ratio is 167.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BrightSpring Health Services, Inc. is 0.62x versus 1.49x for Privia Health Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BTSG
    BrightSpring Health Services, Inc.
    0.62x 59.74x $3.3B $37.5M
    PRVA
    Privia Health Group, Inc.
    1.49x 167.89x $580.4M $9.8M
  • Which has Higher Returns BTSG or SPOK?

    Spok Holdings, Inc. has a net margin of 1.12% compared to BrightSpring Health Services, Inc.'s net margin of 9.46%. BrightSpring Health Services, Inc.'s return on equity of 4.14% beat Spok Holdings, Inc.'s return on equity of 10.88%.

    Company Gross Margin Earnings Per Share Invested Capital
    BTSG
    BrightSpring Health Services, Inc.
    11.76% $0.26 $4.5B
    SPOK
    Spok Holdings, Inc.
    58.95% $0.15 $156.1M
  • What do Analysts Say About BTSG or SPOK?

    BrightSpring Health Services, Inc. has a consensus price target of $40.31, signalling upside risk potential of 12.62%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 61.29%. Given that Spok Holdings, Inc. has higher upside potential than BrightSpring Health Services, Inc., analysts believe Spok Holdings, Inc. is more attractive than BrightSpring Health Services, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    BTSG
    BrightSpring Health Services, Inc.
    11 1 0
    SPOK
    Spok Holdings, Inc.
    1 0 0
  • Is BTSG or SPOK More Risky?

    BrightSpring Health Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.438, suggesting its less volatile than the S&P 500 by 56.19%.

  • Which is a Better Dividend Stock BTSG or SPOK?

    BrightSpring Health Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.6% to investors and pays a quarterly dividend of $0.31 per share. BrightSpring Health Services, Inc. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.

  • Which has Better Financial Ratios BTSG or SPOK?

    BrightSpring Health Services, Inc. quarterly revenues are $3.3B, which are larger than Spok Holdings, Inc. quarterly revenues of $33.9M. BrightSpring Health Services, Inc.'s net income of $37.5M is higher than Spok Holdings, Inc.'s net income of $3.2M. Notably, BrightSpring Health Services, Inc.'s price-to-earnings ratio is 59.74x while Spok Holdings, Inc.'s PE ratio is 16.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BrightSpring Health Services, Inc. is 0.62x versus 1.93x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BTSG
    BrightSpring Health Services, Inc.
    0.62x 59.74x $3.3B $37.5M
    SPOK
    Spok Holdings, Inc.
    1.93x 16.27x $33.9M $3.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 69.73% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 8.64% over the past day.

Sell
13
PSN alert for Dec 8

Parsons Corp. [PSN] is down 5.99% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock